NIH plan targets new COVID-19 tests, point-of-care options

By staff writers

April 29, 2020 -- The National Institutes of Health (NIH) has unveiled an initiative to speed the development and commercialization of COVID-19 testing products and technologies that is funded by $1.5 billion in federal stimulus funding.

The NIH's new Rapid Acceleration of Diagnostics (RADx) initiative aims to promote the advance of diagnostic technologies, in collaboration with the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, and the Biomedical Advanced Research and Development Authority.

NIH hopes to make millions of accurate and easy-to-use tests per week available to all Americans by the end of this summer and more tests available in time for the flu season.

As part of this initiative, NIH is urging scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will face a competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19.

Technologies that already are relatively far along in development would be placed on a separate track and immediately advanced to the appropriate step in the commercialization process.

NIH begins antibody study on undetected coronavirus cases
The National Institutes of Health (NIH) has commenced a study to determine how many adults in the U.S. with no confirmed history of infection with SARS-CoV-2...
New NIH study pinpoints how coronavirus attacks cells
The continued spread of the novel 2019 coronavirus, known as SARS-CoV-2, around the world has raised the need for a test to rapidly and efficiently screen...
NIH offers update on coronavirus outbreak
The U.S. National Institutes of Health (NIH) has weighed in on the outbreak of the deadly coronavirus in China, with officials discussing the agency's...
NIH-funded Lyme test promises better results, at the point of care
A rapid microfluidics assay for Lyme disease performed better than a standard lab workup and shows promise for use as a single diagnostic test at the...
NIH funds human genome reference update
The U.S. National Institutes of Health (NIH) announced on September 24 that it will grant $29.5 million to support researchers to generate and maintain...

Copyright © 2020

Last Updated ls 5/4/2020 11:15:15 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.